Where Can You Give Ozempic Injections? A Complete Guide

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in the brain and pancreas to reduce hunger and regulate blood sugar, with studies showing an average 15% body weight reduction over 68 weeks. Proper injection technique and site rotation are essential for consistent medication delivery and patient comfort. This guide walks you through every aspect of administering semaglutide injections safely at home.

Approved Semaglutide Injection Sites on Your Body

Semaglutide injections are administered subcutaneously—meaning beneath the skin but above muscle tissue. The FDA-approved injection sites include the abdomen, upper arm, and thigh. Each location offers distinct advantages: the abdomen provides easy access and consistent absorption, the upper arm works well for patients with limited abdominal space, and the thigh accommodates self-injection without requiring two hands. Most patients find the abdomen most convenient for weekly dosing.

The abdomen is the most popular injection site because it offers the largest injectable surface area and reliable medication absorption. Inject at least two inches away from your belly button, avoiding any scars, bruises, or areas of hardened skin. The upper arm injection site works best on the back or outer surface—have someone assist with your first injection there, or pinch the skin and inject yourself if you're flexible. The thigh site should target the outer thigh, roughly midway between hip and knee, with at least two fingers' space from bone landmarks.

Site Rotation: Why You Need to Change Injection Locations

Rotating injection sites prevents lipohypertrophy and lipoatrophy—conditions where fat tissue thickens or shrinks at overused injection points. These changes can slow medication absorption and create uneven weight loss results. PlexusDx recommends selecting a new injection site each week, staying within the same general body area for consistency, then moving to a different region the following week. A simple rotation pattern might cycle through four abdominal quadrants, then move to the arms or thighs.

Creating a written rotation chart helps prevent accidental repeat injections in the same spot. Record each injection site and date in a notebook or phone app, rotating through at least 12 different locations across your body over a three-month period. This systematic approach maintains steady medication delivery and reduces injection-site reactions. Patients who rotate properly report fewer injection-site lumps, less pain, and more predictable weight loss outcomes.

Step-by-Step Semaglutide Injection Technique

Before injecting, wash your hands thoroughly and allow the semaglutide pen or syringe to reach room temperature for 30 minutes—cold medication can be more uncomfortable. Examine the solution: it should be clear and colorless; discard it if cloudy, discolored, or contains particles. Wipe the injection site with an alcohol swab and let it air-dry completely. Pinch a fold of skin at your chosen site using one hand, holding it firmly but gently to create a tent of skin suitable for needle insertion.

Using your other hand, insert the needle at a 90-degree angle (perpendicular to your skin) in one swift motion. This angle ensures the medication enters subcutaneous tissue rather than striking muscle. Depress the plunger slowly and steadily over 3-5 seconds, allowing the medication to distribute properly. After injection, withdraw the needle and immediately release the pinched skin. Do not rub the injection site; instead, apply gentle pressure with a clean cotton ball if needed. Most patients report minimal discomfort when technique is correct.

Common Injection Site Issues and How to Prevent Them

Injection-site reactions range from mild redness and swelling to lumps and bruising, typically resolving within hours to days. Bruising occurs when the needle contacts a small blood vessel—this is harmless and preventable through careful site selection and proper technique. Avoid areas with visible veins, scars, or previous injection marks. If you develop a lump or hardened area, skip that region for at least two weeks and apply warm compresses to encourage reabsorption.

Pain at injection sites usually stems from rushing the injection, using cold medication, or injecting into areas with dense nerve endings. Warming the medication and your skin beforehand reduces discomfort significantly. If you experience severe pain during injection, stop immediately and select a different site—you may have hit a nerve. Persistent redness, warmth, pus, or increasing swelling beyond 48 hours may indicate infection and warrants medical evaluation. PlexusDx patients receiving compounded semaglutide from licensed 503A pharmacies receive clear injection training materials with every shipment.

Personalizing Your Treatment with Genetic Insights

Not all patients respond identically to semaglutide because genetic variations influence GLP-1 receptor sensitivity and peptide metabolism. The PlexusDx Precision Peptide Genetic Test identifies key variants including GIPR rs1800437, which directly affect how your body processes semaglutide and related compounds. Understanding your genetic profile helps optimize medication selection, anticipated dosing trajectory, and expected weight loss timing—enabling truly personalized therapy rather than trial-and-error dosing.

The PlexusDx Precision Peptide Genetic Test ($298) reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into the same spot every week?

No—rotating injection sites is critical for preventing lipohypertrophy (thickened fat) and maintaining consistent medication absorption. PlexusDx recommends using a different site each week and tracking injections in a chart to ensure you cycle through at least 12 different locations every three months.

What clinical evidence supports subcutaneous semaglutide injection effectiveness?

The STEP trials (published in the New England Journal of Medicine) demonstrated that weekly subcutaneous semaglutide produced average weight loss of 15% over 68 weeks compared to 2.6% with placebo. Proper injection technique directly correlates with medication bioavailability and therapeutic outcomes.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan across all three commitment tiers. Your dose may need to go up. Your price won't. No insurance is required, and treatment is HSA/FSA eligible.

What should I do if I experience bruising or pain at the injection site?

Mild bruising is normal and usually resolves within days. Avoid that area for two weeks and apply warm compresses to promote healing. If pain is severe during injection, stop and select a different site—you may have contacted a nerve. Persistent warmth, pus, or increasing swelling beyond 48 hours warrants medical evaluation.

How can the PlexusDx Precision Peptide Genetic Test improve my semaglutide results?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Complete Guide Genetic Longevity Testing
• Complete Guide Genetic Muscle Growth Testing
• Complete Guide Genetic Womens Hormone Testing
• Complete Guide Genetic Mens Hormone Testing

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.